Critical limb ischemia

Cardiology Clinics

Volumn 33, Issue 1, 2015, Pages 37-47

  Elsayed, Sarah ^a   Clavijo, Leonardo C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Critical limb ischemia; Diagnosis; Endovascular; Guidelines; Management; Review

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ILOPROST;

ANAMNESIS; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CRITICAL LIMB ISCHEMIA; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG RESPONSE; ENDOVASCULAR SURGERY; HUMAN; HYPERTENSION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LIMB AMPUTATION; LOW DRUG DOSE; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SMOKING CESSATION; SURVIVAL RATE; TREATMENT DURATION; TREATMENT INDICATION; ULTRASOUND; AGED; CROSS-SECTIONAL STUDY; FEMALE; ISCHEMIA; LEG; MALE; MIDDLE AGED; PATIENT REFERRAL; PROGNOSIS; UNITED STATES; VASCULARIZATION;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PROGNOSIS; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 84923147463     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2014.09.008     Document Type: Review

References (26)

1. Golomb B., Dang T., Criqui M. Contemporary reviews in cardiovascular medicine, peripheral arterial disease, morbidity and mortality implications. Circulation 2006, 114:688-699.
2. Allie D.E., Hebert C.J., Ingraldi A., et al. 24-carat gold, 14-carat gold, or platinum standards in the treatment of critical limb ischemia: bypass surgery or endovascular intervention?. JEndovasc Ther 2009, 16(Suppl 1):I134-I146.
3. Hirsch A., Haskal Z., Hertzer N., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463-e654.
4. Mills J., Conte M., Armstrong D., et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). JVasc Surg 2014, 59:220-234.
5. Elsayed S., Theophanous C., Upadhyay R., et al. Contemporary preoperative evaluation of patients with critical limb ischemia undergoing vascular surgery. Catheter Cardiovasc Interv 2014, 83(S1):S76.
6. Kobayashi N., Hirano K., Nakano M., et al. Predictors of non-healing in patients with critical limb ischemia and tissue loss following successful endovascular therapy. Catheter Cardiovasc Interv 2014, [Epub ahead of print].
7. McPhee J., Barshes N., Ho K., et al. Predictors factors of 30-day unplanned readmission after lower extremity bypass. JVasc Surg 2013, 57:955-962.
8. Iida O., Soga Y., Hirano K., et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. JVasc Surg 2012, 55:363-370.
9. White C. Intermittent claudication. NEngl J Med 2007, 356:1241-1250.
10. Rooke T., Hirsch A., Misra S., et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Circulation 2011, 124:2020-2045.
11. Anderson J., Halperin J., Albert N., et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013, 127:1425-1443.
12. Conte M., Bandyk D., Clowes A., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. JVasc Surg 2006, 43:742-751.
13. Mohler E., Giri J. Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines. Curr Med Res Opin 2008, 24:2509-2522.
14. Stone N., Robinson J., Lichtenstein A., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 2014, 129(25 Suppl 2):S1-S45.
15. Hirsch A., Criqui M., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
16. Elsayed S., Shavelle D., Matthews R., et al. Aspirin and clopidogrel high on treatment platelet reactivity "resistance" in critical limb ischemia. JAm Coll Cardiol 2012, 59(13s1):E2114.
17. Spiliopoulos S., Pastromas G., Katsanos K., et al. Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity. JAm Coll Cardiol 2013, 61:2428-2434.
18. Sultan S., Hamada N., Soylu E., et al. Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease. JVasc Surg 2011, 54:440-446.
19. Bradbury A., Adam D., Bell J., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. JVasc Surg 2010, 51:5S-17S.
20. Bradbury A., Adam D., Bell J., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. JVasc Surg 2010, 51(5 Suppl):52S-68S.
21. Feiring A., Krahn M., Nelson L., et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents. The PaRADISE (PReventing Amputations using Drug eluting StEnts) Trial. JAm Coll Cardiol 2010, 55:1580-1589.
22. Egorova N., Guillerme S., Gelijns A., et al. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. JVasc Surg 2010, 51:878-885. 885.e1.
23. Slim H., Tiwari A., Ritter J., et al. Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia. JVasc Surg 2011, 53:421-425.
24. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007, 45(Suppl S):S5-67.
25. Feiring A., Krahn M., Nelson L., et al. Preventing leg amputations in critical limb ischemia with below the-knee drug-eluting stents. The PaRADISE (PReventing Amputations using Drug eluting StEnts) Trial. J Am Coll Cardiol 2010, 55:1580-1589.
26. Bradbury A., Adam D., Bell J., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010, 51:5S-17S.